Communiqués Regnum Corp.

Actions

RGMP

US75915R1068

Temps Différé OTC Markets Autres places de cotation 21:46:41 12/07/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-99,00 %		0,00 %	0,00 %

2023	Regnum Corp. annonce la démission d'Anne Kirby de son poste de directeur général	CI
2023	Regnum Corp. annonce la démission d'Anne Kirby en tant qu'unique membre du conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	17/04/23	AQ
REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/11/22	AQ
REGNUM CORP. : Other Events (form 8-K)	31/10/22	AQ
REGNUM CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	13/10/22	AQ
REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/08/22	AQ
Regnum : Termination of a Material Definitive Agreement - Form 8-K	31/05/22	PU
REGNUM CORP. : Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	31/05/22	AQ
REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23/05/22	AQ
REGNUM CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	28/04/22	AQ
REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/04/22	AQ
Regnum Signs Assignment and Assumption Agreement with CytoDyn and SevenScore Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV	10/01/22	PR
REGNUM CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07/01/22	AQ
REGNUM CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23/11/21	AQ
REGNUM CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	13/10/21	AQ
REGNUM CORP. : Termination of a Material Definitive Agreement (form 8-K)	01/09/21	AQ
REGNUM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	31/08/21	AQ
REGNUM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20/08/21	AQ
REGNUM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	13/08/21	AQ
REGNUM CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	04/08/21	AQ
REGNUM CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20/05/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Regnum Corp.

Actions

RGMP

US75915R1068

Communiqués

Filtres